Low-dose interleukin-2 promotes STAT-5 phosphorylation, T survival and CTLA-4-dependent function in autoimmune liver diseases. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cei.12940

PubMed Identifier: 28176332

Publication URI: http://europepmc.org/abstract/MED/28176332

Type: Journal Article/Review

Volume: 188

Parent Publication: Clinical and experimental immunology

Issue: 3

ISSN: 0009-9104